Climara Pro is a drug owned by Bayer Healthcare Pharmaceuticals Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Oct 14, 2014. Details of Climara Pro's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5676968 | Transdermal therapeutic systems with crystallization inhibitors |
Oct, 2014
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Climara Pro is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Climara Pro's family patents as well as insights into ongoing legal events on those patents.
Climara Pro's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Climara Pro's generic launch date based on the expiry of its last outstanding patent is estimated to be Oct 14, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Climara Pro Generics:
There are no approved generic versions for Climara Pro as of now.
Alternative Brands for Climara Pro
There are several other brand drugs using the same active ingredient (Estradiol; Levonorgestrel) as Climara Pro. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||||
|---|---|---|---|---|---|---|
| Agile |
| |||||
| Avion Pharms |
| |||||
| Teva Branded Pharm |
| |||||
| Wyeth Pharms Inc |
|
About Climara Pro
Climara Pro is a drug owned by Bayer Healthcare Pharmaceuticals Inc. Climara Pro uses Estradiol; Levonorgestrel as an active ingredient. Climara Pro was launched by Bayer Hlthcare in 2003.
Approval Date:
Climara Pro was approved by FDA for market use on 21 November, 2003.
Active Ingredient:
Climara Pro uses Estradiol; Levonorgestrel as the active ingredient. Check out other Drugs and Companies using Estradiol; Levonorgestrel ingredient
Dosage:
Climara Pro is available in film, extended release form for transdermal use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.045MG/24HR;0.015MG/24HR | FILM, EXTENDED RELEASE | Prescription | TRANSDERMAL |